Opaleye Management Inc. Regulus Therapeutics Inc. Transaction History
Opaleye Management Inc.
- $548 Million
- Q3 2024
A detailed history of Opaleye Management Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 535,000 shares of RGLS stock, worth $823,900. This represents 0.15% of its overall portfolio holdings.
Number of Shares
535,000
Previous 1,475,000
63.73%
Holding current value
$823,900
Previous $2.64 Million
68.22%
% of portfolio
0.15%
Previous 0.68%
Shares
3 transactions
Others Institutions Holding RGLS
# of Institutions
74Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$19.8 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$9.96 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.7 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.57 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$6.3 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $22.5M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...